Citi Pharma (KAR:CPHL) Dividend Payout Ratio : 0.00 (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is Citi Pharma Dividend Payout Ratio?

Citi Pharma's dividend payout ratio for the months ended in . 20 was 0.00.

The historical rank and industry rank for Citi Pharma's Dividend Payout Ratio or its related term are showing as below:

KAR:CPHL's Dividend Payout Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.34
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-07), the Dividend Yield % of Citi Pharma is 8.72%.

During the past 0 years, the highest Trailing Annual Dividend Yield of Citi Pharma was 12.01%. The lowest was 0.00%. And the median was 0.00%.

Citi Pharma's Dividends per Share for the months ended in . 20 was ₨0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Citi Pharma Dividend Payout Ratio Historical Data

The historical data trend for Citi Pharma's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citi Pharma Dividend Payout Ratio Chart

Citi Pharma Annual Data

Trend

Dividend Payout Ratio

Citi Pharma Semi-Annual Data

Dividend Payout Ratio

Competitive Comparison of Citi Pharma's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Citi Pharma's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Citi Pharma's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Citi Pharma's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Citi Pharma's Dividend Payout Ratio falls into.

Citi Pharma Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Citi Pharma's Dividend Payout Ratio for the fiscal year that ended in . 20 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: . 20 )	/	EPS without NRI (A: . 20 )
	=		/
	=	N/A

Citi Pharma's Dividend Payout Ratio for the quarter that ended in . 20 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: . 20 )	/	EPS without NRI (Q: . 20 )
	=		/
	=	N/A

Citi Pharma (KAR:CPHL) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Citi Pharma Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Citi Pharma's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Citi Pharma (KAR:CPHL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citi Pharma Ltd (KAR:CPHL) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

588 Q Block, Johar Town, Lahore, PB, PAK

Website

http://www.citipharma.com.pk

Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its departments include Active Pharma Ingredients (API) and Formulations. Some of its products include Askprol C Tab, Lenon Tab, Recoz Tab, Cingol Tab among others.

Citi Pharma (KAR:CPHL) Headlines

No Headlines